M-PACT sets new standard for pediatric brain tumor diagnostics, treatment monitoring
M-PACT sets new standard for pediatric brain tumor diagnostics, treatment monitoring is drawing significant interest across the industry.
Liquid biopsies, which test body fluids that contain cancerous material, including circulating tumor DNA (ctDNA), are a noninvasive way to learn about a cancer's biology.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Burned Out From Business Paperwork? This AI Platform Handles the Busywork-50% Off Today
- Ray-Ban Meta (Gen 2) Smart AI Glasses Get a Sudden Price Drop, Now at a Record Low on Amazon
- My sugar is fine, but I feel terrible: Doctor explains what your diabetes report may be missing
- Detecting the "scent" of ovarian cancer with AI
Source: Original →